F. Husseini

Cetuximab+FOLFIRI as first-line treatment for metastatic colorectal CA

P. Rougier, Jean‐Luc Raoul, Jean‐Luc Van Laethem et al. · Journal of Clinical Oncology · 2004 · 88 citations

Folfiri Regimen, Cancer Therapeutics, Gastrointestinal Oncology +15

Multicentre phase II study of oxaliplatin as a single-agent in cisplatin/carboplatin ± taxane-pretreated ovarian cancer patients

Véronique Dièras, Philippe Bougnoux, Thierry Petit et al. · Annals of Oncology · 2002 · 67 citations

Oncology, Medicine, Gynecology +5

Docetaxel Plus Gemcitabine or Docetaxel Plus Cisplatin in Advanced Pancreatic Carcinoma: Randomized Phase II Study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group

Manfred P. Lutz, Eric Van Cutsem, Theo Wagener et al. · Journal of Clinical Oncology · 2005 · 46 citations · Full text

Bevacizumab Combined With Chemotherapy in the Second-Line Treatment of Metastatic Colorectal Cancer: Results from the Phase II BEVACOLOR Study

Jaafar Bennouna, Christophe Borg, Jean‐Pierre Delord et al. · Clinical Colorectal Cancer · 2011 · 31 citations

Second-line Treatment, Surgical Oncology, Medicine +6

Vectorized gene therapy of liver tumors: proof-of-concept of TG4023 (MVA-FCU1) in combination with flucytosine

F. Husseini, Jean‐Pierre Delord, Cécile Fournel-Federico et al. · Annals of Oncology · 2016 · 30 citations · Full text

Tumor Biology, Hepatology, Novel Therapy +8